ArticleWorld journal of surgical oncology2012

Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.

You-Feng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.